Can Radiation Cause Thyroid Problems?

Radiation is one of the best-established environmental causes of thyroid disease. It can trigger thyroid cancer, hypothyroidism, benign nodules, and autoimmune thyroid conditions, with the risk depending on the dose, the type of radiation, and the age at which someone is exposed. The thyroid gland is unusually sensitive to radiation compared to most other organs, and the clearest proof comes from decades of follow-up after nuclear disasters and medical exposures. But the story is more complicated than “radiation equals thyroid cancer,” and the range of thyroid problems radiation can cause is broader than most people realize.

Why the Thyroid Is Especially Vulnerable

The thyroid gland actively concentrates iodine from the bloodstream to make its hormones. That same mechanism turns into a liability when radioactive iodine is present, because the gland pulls in radioactive iodine-131 just as eagerly as the stable kind. Once inside, the radioactive iodine delivers a concentrated dose of radiation to thyroid cells from within. This is why nuclear fallout that contains iodine-131 poses such a specific threat to the thyroid, and why radioactive iodine is also used medically to treat thyroid overactivity and thyroid cancer.

Even external radiation that does not involve iodine-131 can damage the thyroid. Gamma radiation, for instance, causes chromosomal rearrangements in thyroid cells in a dose-dependent way. Laboratory studies have shown that exposing human thyroid cells to gamma radiation produces specific genetic rearrangements called RET/PTC fusions, which are known drivers of papillary thyroid cancer. The rate of these rearrangements increased as the radiation dose went up, providing a direct mechanistic link between radiation exposure and thyroid cancer development.

What Chernobyl Taught Us

The 1986 Chernobyl nuclear accident became the defining case study for radiation-induced thyroid disease. Radioactive iodine-131 was released in large quantities and entered the food chain, especially through contaminated milk. Children in Belarus, Ukraine, and parts of Russia absorbed high thyroid doses, and in the years that followed, thyroid cancer rates in those regions climbed dramatically. Between 1991 and 2015, more than 19,000 thyroid cancer cases were registered among people who had been under 18 at the time of the accident in the most contaminated areas of Belarus, Ukraine, and Russia.

The cancers were overwhelmingly papillary thyroid carcinomas, and researchers have spent decades working out which ones were truly caused by radiation and which would have occurred anyway. A 2025 genomic study tackled this by looking at the molecular profiles of post-Chernobyl thyroid cancers. One specific type of chromosomal fusion, generated from two breakpoints with very small amounts of DNA gained or lost, increased in frequency as the estimated thyroid radiation dose went up. Other common drivers of papillary thyroid cancer, including the well-known BRAF mutation, did not show this pattern. The researchers also found that mutational “clock” signatures, which mark when a tumor first started forming, lined up with the age at the time of the accident only for the radiation-associated fusion type.

This matters because it means scientists can now distinguish, at the molecular level, which thyroid cancers bear a radiation fingerprint and which are likely sporadic. Gene expression studies have separately identified a panel of seven genes that completely differentiated post-Chernobyl cancers from sporadic ones, with the radiation-induced tumors showing expression patterns associated with more aggressive behavior.

⁴

Children Face the Highest Risk

One of the most consistent findings across radiation and thyroid research is that younger people are far more vulnerable. A large pooled analysis combining data from 12 studies of thyroid cancer after childhood radiation exposure, covering more than 5 million person-years and over 1,000 thyroid cancers, found that the excess risk per unit of radiation dose increased the younger a person was at the time of exposure.

⁵

The Chernobyl experience reinforced this pattern starkly. The biggest jump in papillary thyroid cancer occurred in children aged 0 to 14 at the time of the accident, and researchers noted that existing iodine deficiency in the affected populations may have compounded the problem by making thyroid glands hungrier for any iodine they could get, including the radioactive kind.

⁶

The pooled analysis also found that the risk was the same regardless of sex and whether someone had been exposed once or multiple times; what mattered most was how young they were and how large the dose was.

⁵

Beyond Cancer: Hypothyroidism, Nodules, and Autoimmune Disease

Thyroid cancer grabs headlines, but radiation causes a wider spectrum of thyroid problems. High-dose radiation, whether from an external source or from radioactive iodine, is strongly associated with hypothyroidism, where the thyroid can no longer produce enough hormone. Studies have found hypothyroidism rates ranging from about 2% to 31% after high-dose exposure, depending on the dose and the population studied. Graves’ disease, an autoimmune form of hyperthyroidism, has also been linked to radiation, with rates reaching up to 5% in some exposed groups.

⁷

Radiation exposure is also recognized as a risk factor for autoimmune thyroid disease more broadly. A review of environmental triggers for autoimmune thyroid conditions identified both nuclear fallout and medical radiation as exposures that increase the risk, alongside factors like high iodine intake and certain environmental contaminants.

⁸

Data from atomic bomb survivors in Hiroshima and Nagasaki, examined 55 to 58 years after the bombings, showed a clear dose-response relationship for solid thyroid nodules, benign nodules, malignant tumors, and even thyroid cysts. At the average thyroid dose received by the study population, researchers estimated that roughly 37% of malignant tumors, 31% of benign nodules, and 25% of cysts were attributable to radiation exposure.

⁹

Radiation Therapy for Head and Neck Cancer

One of the most common medical settings where radiation causes thyroid damage is during treatment for head and neck cancer. The thyroid sits in the neck, and when radiation beams are aimed at tumors in that area, the thyroid often absorbs a substantial dose. Recent estimates suggest that 40 to 50% of patients may develop hypothyroidism after radiation therapy for head and neck cancer.

¹⁰

The risk increases with higher radiation doses to the thyroid and the pituitary gland, and it keeps climbing with longer follow-up, meaning patients who are monitored for years are more likely to be diagnosed than those checked only in the short term.

¹¹

This is a predictable side effect rather than a surprise complication, and oncologists typically monitor thyroid function with regular blood tests after treatment. If hypothyroidism develops, thyroid hormone replacement medication is straightforward and effective. But the sheer frequency of this outcome, affecting roughly half of patients, underscores how sensitive thyroid tissue is to therapeutic radiation doses.

Diagnostic Imaging and Low-Dose Exposure

What about the much lower doses of radiation from medical imaging? This is a murkier area. A meta-analysis pooling seven studies found that people who had undergone multiple dental X-rays had roughly double the risk of thyroid cancer compared to those who had not, though the confidence interval was wide.

¹²

A case-control study looking specifically at very small thyroid cancers (tumors 10 mm or smaller) found increased risk associated with several types of diagnostic imaging, including chest X-rays, CT scans of the head and neck, and mammograms. The associations were strongest for nuclear medicine examinations and CT scans. Interestingly, these associations were only seen for tiny tumors, not for larger ones, which raises the question of whether improved detection played a role alongside any true increase in cancer caused by the radiation.

¹³

The evidence here is much less definitive than for high-dose exposures. The doses from a single X-ray or CT scan are small, and the studies finding associations are mostly case-control designs that rely on people remembering their imaging history, which introduces bias. For any individual patient, the benefit of a medically necessary scan almost always outweighs the small hypothetical thyroid risk. But the research does suggest that cumulative exposure from many scans over a lifetime deserves some thought, and it supports the routine practice of using thyroid shields during dental X-rays when possible.

Radioactive Iodine Treatment for Graves’ Disease

Radioactive iodine-131 is used deliberately to destroy overactive thyroid tissue in people with Graves’ disease. The intended outcome, ironically, is to cause thyroid damage: by knocking out enough thyroid cells, the treatment brings hormone levels back to normal or, more commonly, tips the patient into hypothyroidism that is then managed with daily medication. This is considered an acceptable and planned trade-off because uncontrolled hyperthyroidism carries its own serious risks.

In one study of patients followed for six months after radioactive iodine treatment for Graves’ disease, about 70% had already developed hypothyroidism. The patients most likely to become hypothyroid early were men, those with smaller thyroid glands, and those whose glands took up less iodine beforehand.

¹⁴

Another factor predicting hypothyroidism after radioactive iodine treatment is the presence of thyroid peroxidase (TPO) antibodies, a marker of autoimmune activity against the thyroid. Patients who tested positive for TPO antibodies before treatment had substantially higher odds of developing hypothyroidism afterward.

¹⁵

Lifelong monitoring is the standard after radioactive iodine therapy, because hypothyroidism can develop months or years later even in patients who initially seem fine.

¹⁶

Occupational Exposure for Healthcare Workers

People who work with radiation daily, such as radiology technicians, nuclear medicine staff, and interventional cardiologists, face chronic low-dose exposure that has raised concerns about thyroid health. A review of the literature found that healthcare workers exposed to occupational radiation tend to have a higher prevalence of thyroid nodules than the general population, though whether those nodules are more likely to be malignant remains unclear.

¹⁷

A study of nuclear power plant employees found they had more than four times the odds of elevated TSH levels compared to an unexposed reference group.

¹⁸

Similarly, a study of healthcare workers exposed to ionizing radiation found they had significantly higher average TSH and lower average thyroid hormone levels than unexposed colleagues, with about 9% of exposed workers meeting criteria for hypothyroidism.

¹⁹

These findings are hard to interpret definitively because of confounding factors and differences in how studies were designed, but they reinforce the importance of thyroid shielding and regular monitoring for workers in radiation-heavy specialties.

The Dose-Response Relationship and Latency

Radiation’s effect on the thyroid follows a dose-response curve, meaning higher doses generally produce more disease. For thyroid cancer and benign nodules, the relationship at low to moderate doses is consistent with a linear pattern: double the dose, roughly double the excess risk.

²⁰

At very high doses, however, the curve bends downward. A study of childhood cancer survivors who received high-dose radiation therapy found that the excess risk per gray peaked below about 6 Gy and then declined at higher doses, likely because very high doses kill thyroid cells outright rather than leaving them alive but genetically damaged. At 20 Gy the excess risk per unit dose had dropped by roughly half, and at 40 Gy it had dropped by about 95%.

²¹

This “cell-killing effect” at high doses explains a seeming paradox: patients who receive very high radiation doses to the neck during cancer treatment are more likely to develop hypothyroidism (because their thyroid cells are destroyed) but not necessarily more likely to develop a new thyroid cancer (because the cells that might have become cancerous are dead too).

Thyroid cancers caused by radiation do not appear immediately. The minimum latency period is estimated at 5 to 10 years after exposure, and the risk remains elevated for decades.

²²

Potassium Iodide and Iodine Status

If you flood the thyroid with stable, non-radioactive iodine before or shortly after exposure to radioactive iodine, the gland takes up less of the dangerous isotope because it is already saturated. This is the rationale behind potassium iodide (KI) tablets, which governments stockpile near nuclear facilities for emergency distribution. Taking KI within two hours of exposure to iodine-131 can block about 79% of thyroid uptake in adults.

²³

Timing is critical. KI works best when taken just before or very soon after exposure; its effectiveness drops substantially with each passing hour. It also only protects against radioactive iodine specifically, not against other types of radiation.

²⁴

Your baseline iodine status matters too. A thyroid that is iodine-deficient is hungrier for any iodine it encounters and will absorb a larger proportion of radioactive iodine than a well-nourished gland. Animal research has shown that iodine-deficient thyroid glands absorb more radioiodine and hold onto it longer, while supplementing with organic iodine reduces uptake and speeds excretion.

²⁵

This connection between iodine deficiency and radiation vulnerability helps explain why populations in parts of Eastern Europe, where iodine deficiency was common in the 1980s, were hit so hard by Chernobyl fallout.

Radiation Exposure During Pregnancy

Fetal exposure to radiation is a particular concern because the developing thyroid begins concentrating iodine around 10 to 12 weeks of gestation. Before implantation, high-dose radiation can kill the embryo, but surviving embryos at that very early stage are unlikely to develop thyroid dysfunction. The danger window opens during organogenesis: from about 10 weeks onward, exposure to radioactive iodine at doses above 100 to 300 milligray can result in fetal thyroid ablation, other malformations, and growth restriction.

²⁶

A case report of a woman who received radioactive iodine for thyrotoxicosis while unknowingly 19 weeks pregnant illustrates the stakes. Fetal thyroid hormone levels measured in utero were normal or mildly elevated, but fetal TSH was very high, signaling that the fetal thyroid was already struggling.

²⁷

This is why pregnancy testing is required before administering radioactive iodine therapy, and why pregnant women are advised to avoid areas of nuclear contamination when possible. The fetal thyroid, once it starts concentrating iodine, is at least as vulnerable as a child’s.

The Fukushima Screening Debate

After the 2011 Fukushima nuclear accident, Japanese authorities launched a massive thyroid ultrasound screening program for children in the affected prefecture. By the time data had accumulated, over 200 children had been diagnosed with thyroid cancer, and the numbers were far higher than expected based on normal rates.

²⁸

At first glance, this looked alarming. One analysis found that the observed prevalence of thyroid cancer among Fukushima residents aged 20 and under was roughly 30 times higher than expected.

²⁹

But several lines of evidence suggest that much of this excess is likely overdiagnosis rather than radiation-caused cancer. First, radiation doses to the thyroid from Fukushima were much lower than those from Chernobyl. Second, thyroid cancers did not show a dose-dependent geographic pattern: municipalities with higher estimated doses did not have higher detection rates.

³⁰

Third, the cancers were being detected within four to six years of the accident, which is at the very edge of the expected minimum latency for radiation-induced thyroid cancer. And fourth, when you do high-resolution ultrasound screening on large numbers of healthy children, you inevitably find tiny, slow-growing thyroid cancers that might never have caused symptoms. This phenomenon, where screening finds disease that would not have become clinically relevant, is well documented in thyroid cancer research. The Fukushima experience became a cautionary tale about the harms of mass screening as much as about radiation itself, and it remains a subject of active scientific debate.

What This Means If You Have Been Exposed

If you have had significant radiation exposure, whether from a nuclear event, cancer treatment, or accumulated occupational doses, long-term thyroid monitoring is warranted. The standard approach is periodic blood tests to check thyroid hormone and TSH levels, and in some cases thyroid ultrasound. Given the long latency period, this monitoring needs to continue for decades, not just a few years.

If you work in a radiation-heavy field, wearing a thyroid shield collar during procedures and ensuring your workplace follows established radiation protection protocols matters. And if you live near a nuclear facility, knowing where to get potassium iodide and understanding that it must be taken within hours of exposure, not days, could make a real difference in a genuine emergency. The thyroid’s vulnerability to radiation is well established, but so are the practical steps that reduce the risk.